Search

Your search keyword '"B. Schmerboeck"' showing total 18 results

Search Constraints

Start Over You searched for: Author "B. Schmerboeck" Remove constraint Author: "B. Schmerboeck"
18 results on '"B. Schmerboeck"'

Search Results

1. Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis

2. Dysbiosis in early sepsis can be modulated by a multispecies probiotic: a randomised controlled pilot trial

3. Functional response of neutrophils is associated with serum bile acids profile in liver cirrhotic patients

4. Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation

5. Direct acting anti-viral therapy rescues neutrophil dysfunction in hepatitis C infection by reduction of heamolysis

6. A single alcohol binge impacts on neutrophil function without changes in gut barrier function and gut microbiome composition in healthy volunteers

7. A multispecies probiotic enhances antimicrobial activity in cirrhosis: A randomized, double blind placebo-controlled study

8. Acellular growth retardation ability (AGRA), a novel biomarker for humoral immune function, predicts the occurrence of severe bacterial infections in cirrhosis

9. Changes of bile acids profile in different etiologies of liver cirrhosis and its association with neutrophil response

10. Loss of colonization resistance in cirrhosis facilitates proton pump inhibitor-associated oralization of the colonic microbiome

12. Dysbiosis of the gut microbiota and increased gut permeability characterize secondary sclerosing cholangitis in critically ill patients (SSC-CIP)

13. Macrophage activation markers sCD163 and mannose receptor predict survival and correlate with markers of gut permeability in patients with liver cirrhosis

14. Intestinal colonisation by Veillonella spp. is predictive for mortality in stable cirrhosis and could be partially reduced by a multispecies probiotic in a randomized placebo controlled trial

15. Multispecies Probiotic Maintains Health Related Quality of Life in Cirrhosis Better than Placebo

16. Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis.

17. Dysbiosis in early sepsis can be modulated by a multispecies probiotic: a randomised controlled pilot trial.

18. Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis.

Catalog

Books, media, physical & digital resources